The injectable SINUX nucleus replacement device is made from a cold-curing, permanently-elastic polymer consisting of a modified polydimethylsiloxane and a platinum catalyst. It replaces the nucleus material that is removed during nucleotomy and conforms to the shape of the void created within the annulus fibrosus.
Injection of the SINUX nucleus replacement can be achieved via normal surgical approaches to the lumbar intervertebral discs. The position of the patient during surgery is not critical and established surgical techniques for standard discectomy or microdiscectomy do not need to be modified.
SINUX nucleus replacement is used as an adjunct to primary nucleotomy procedures or to treat DDD patients at an early stage and is intended to reduce the incidence of post-nucleotomy syndrome and improve long-term outcomes.
![]() |
![]() |
![]() |
CE Certification: 2846DE410070330
Video animation I: Sinux surgery after disc herniation
Video animation II: Sinux surgery after degenerative disc disease